InMode Ltd. (INMD)

Verve Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	178.7	181.28	197.92	161.52	164.97	75.03
Depreciation & Amortization	0.75	0.73	0.62	0.68	0.52	0.42
Loss (Gain) From Sale of Investments	0.03	0.17	-	0.07	0.18	0.01
Stock-Based Compensation	13.36	16.57	23.6	24.45	11.96	12.85
Provision & Write-off of Bad Debts	0.34	0.57	1.02	0.45	0.52	0.44
Other Operating Activities	-50.12	-59.58	-4.9	-1.13	0.56	1.1
Change in Accounts Receivable	2.71	5.95	-16.08	-10.42	-10.54	-4.42
Change in Inventory	-15.48	-14.45	-5.2	-18.87	-6.04	-5.58
Change in Accounts Payable	1.93	-0.18	-2.28	7.46	2.37	2.71
Change in Unearned Revenue	-30.71	5.4	-3.07	1.2	2.67	-5.51
Change in Other Net Operating Assets	3.08	-3.78	-14.81	16.15	7.74	2.18
Operating Cash Flow	104.61	132.66	176.83	181.58	174.89	79.23
Operating Cash Flow Growth	-38.06%	-24.98%	-2.62%	3.83%	120.74%	27.36%
Capital Expenditures	-0.62	-0.67	-0.71	-1.58	-0.94	-0.46
Investment in Securities	339.63	162.88	-135.36	-107.9	-159.17	-42.84
Investing Cash Flow	339.01	162.21	-136.06	-109.47	-160.11	-43.31
Issuance of Common Stock	2.98	2.61	5.5	1.55	20.34	4.78
Repurchase of Common Stock	-323.85	-285.39	-	-42.64	-35.37	-17.22
Financing Cash Flow	-320.87	-282.77	5.5	-41.09	-15.02	-12.44
Foreign Exchange Rate Adjustments	1.49	-1.18	0.61	-1.62	-0.56	0.73
Net Cash Flow	124.24	10.92	46.87	29.4	-0.8	24.21
Free Cash Flow	103.99	132	176.12	180	173.95	78.76
Free Cash Flow Growth	-38.23%	-25.05%	-2.16%	3.48%	120.85%	28.04%
Free Cash Flow Margin	25.90%	33.43%	35.79%	39.63%	48.65%	38.21%
Free Cash Flow Per Share	1.47	1.64	2.05	2.11	2.02	0.94
Cash Income Tax Paid	17.69	17.69	31.61	25.84	1.66	0.22
Levered Free Cash Flow	39.67	78.31	105.23	149.35	107.56	51.44
Unlevered Free Cash Flow	39.67	78.31	105.23	149.35	107.56	51.44
Change in Net Working Capital	45.47	8.65	40.57	-2.14	8.65	6.88

Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q